-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
Optimized Method to Generate Well-Characterized Macrophages from Induced Pluripotent Stem Cells
Published 2025-01-01Get full text
Article -
52
Adipocyte-specific Steap4 deficiency reduced thermogenesis and energy expenditure in mice
Published 2025-02-01Get full text
Article -
53
Ulcerative Cutaneous Lesions Synchronously Present with the Diagnosis of Primary Lung Cancer
Published 2013-01-01Get full text
Article -
54
Multicentric Castleman’s Disease, Associated with Idiopathic Thrombocytopenic Purpura
Published 2013-01-01Get full text
Article -
55
Pneumocystis Pneumonia Presenting as an Enlarging Solitary Pulmonary Nodule
Published 2016-01-01Get full text
Article -
56
EEG Correlates of Central Origin of Cancer-Related Fatigue
Published 2020-01-01Get full text
Article -
57
Safety of Colonoscopies in Patients on Advanced Heart Failure Therapies Who Received a Heart Transplant
Published 2025-01-01Get full text
Article -
58
Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations
Published 2025-02-01“…Matthew Stewart,1 Jessica L Geiger2 1Department of Internal Medicine, Primary Care Institute, Cleveland Clinic Foundation, Cleveland, OH, USA; 2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USACorrespondence: Matthew Stewart, Department of Internal Medicine, Primary Care Institute Cleveland Clinic Foundation, Cleveland, OH, USA, Email stewarm7@ccf.org Jessica L Geiger, Department of Hematology and Medical Oncology, Taussig Cancer Institute Cleveland Clinic Foundation, Cleveland, OH, USA, Email geigerj@ccf.orgAbstract: The treatment of locally advanced cutaneous squamous cell carcinoma (cSCC) has shifted with the advent of immune checkpoint inhibitors (ICIs). …”
Get full text
Article -
59
-
60